Michael P. Bailey

SVP, Commercial Ops, IMCLONE SYSTEMS INC.

Companies

Verastem OncologyBoard member May 27, 2026 to now¹
AVEO PHARMACEUTICALS, INC.Board member Jan 8, 2015 to Jan 19, 2023²
AVEO PHARMACEUTICALS, INC.Chief executive officer Jan 8, 2015 to Jan 19, 2023²
AVEO PHARMACEUTICALS, INC.President Jan 8, 2015 to Jan 19, 2023²
AVEO PHARMACEUTICALS, INC.Chief Commercial Officer Sep 17, 2010 to Jun 23, 2014³
MADRIGAL PHARMACEUTICALS, INC.Sr. VP, Chief Comm. Officer Aug 6, 2008 to Aug 6, 2010⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Verastem Oncology VSTM108,000 shares⁵$993.1K at $9.20May 21, 2026
AVEO PHARMACEUTICALS, INC.0 shares⁶Jan 19, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 21, 2026Granted 108,000 shares of Verastem Oncology⁵
Jan 19, 2023Returned to company 333,167 shares at $15.00 of AVEO PHARMACEUTICALS, INC.⁶
Dec 20, 2022Exercised options 164,525 shares at $3.67 of AVEO PHARMACEUTICALS, INC.⁷
Dec 20, 2022Exercised options 85,722 shares at $5.60 of AVEO PHARMACEUTICALS, INC.⁷
Dec 20, 2022Exercised options 26,499 shares at $6.20 of AVEO PHARMACEUTICALS, INC.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVerastem Oncology, Board member
2
SEC EDGARAVEO PHARMACEUTICALS, INC., Board member
3
SEC EDGARAVEO PHARMACEUTICALS, INC., Chief Commercial Officer
4
SEC EDGARMADRIGAL PHARMACEUTICALS, INC., Sr. VP, Chief Comm. Officer
5
SEC EDGARVerastem Oncology shares after the filing of May 21, 2026
6
SEC EDGARAVEO PHARMACEUTICALS, INC. shares after the filing of Jan 19, 2023
7
SEC EDGARForm 4 filed Dec 22, 2022